Author

J. Cuenca-Escalona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Y. Dolen· 2 shared A. Cammarata· 1 shared A. M. D. Becker· 1 shared A. Rodgers Furones· 1 shared A. van Spriel· 1 shared C. G. Figdor· 1 shared C. M. Le Gall· 1 shared G. Florez-Grau· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Y. Dolen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Galectin-9 regulates dendritic cell polarity and uropod contraction by modulating RhoA activity

G. Franken, J. Cuenca-Escalona, I. F. Stehle, V. van Reijmersdal, A. Rodgers Furones, R. R. Gokhale, R. Classens, S. diBlasio, Y. Dolen, A. van Spriel, L. Querol Cano

This study shows galectin-9 regulates dendritic cell migration by modulating RhoA activity and CD44-mediated rear contractility in both humans and mice.

bioRxiv · Oct 30, 2023 · PreprintImmunology

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

C. M. Le Gall, A. Cammarata, L. de Haas, I. Ramos-Tomillero, J. Cuenca-Escalona, Z. Wijfjes, A. M. D. Becker, Y. Dolen, I. J. M. de Vries, C. G. Figdor, G. Florez-Grau, M. Verdoes

This study demonstrates that targeting NY-ESO-1 antigen to human cDC1s via XCL1(CC3) enhances cross-presentation and CD8+ T cell activation.

bioRxiv · Nov 30, 2021Immunology